https://doi.org/10.1186/s13059-018-1594-y
Y
Yan Xu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
68
Papers
1.3K
Citations
16
h-index
19
i10-index
Yan Xu is an academic researcher from Qingdao University. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & RNA modifications and cancer & Cancer Immunotherapy and Biomarkers. The author has an h-index of 16, co-authored 58 publications.
ORCID: 0000-0002-9596-2979Papers by this author
worksA novel FLI1 exonic circular RNA promotes metastasis in breast cancer by coordinately regulating TET1 and DNMT1
2018 · Genome biology · 469 citations
Prevalence of Dyslipidemia and Availability of Lipid-Lowering Medications Among Primary Health Care Settings in China
2021 · JAMA Network Open · 191 citations
https://doi.org/10.1001/jamanetworkopen.2021.27573
Expression of <scp>HMGA</scp>2 in bladder cancer and its association with epithelial‐to‐mesenchymal transition
2014 · Cell Proliferation · 47 citations
https://doi.org/10.1111/cpr.12096
Benign fibrous histiocytoma of parietal bone: case report and review of the literature
2015 · World Journal of Surgical Oncology · 9 citations
https://doi.org/10.1186/s12957-015-0587-5
Tumor-derived miR-203a-3p potentiates muscle wasting by inducing muscle ferroptosis in pancreatic cancer
2025 · Cancer Letters · 9 citations
https://doi.org/10.1016/j.canlet.2025.217523
Primary carcinoid tumor of medulla spinalis: case report and review of the literature
2014 · European journal of medical research · 7 citations
https://doi.org/10.1186/s40001-014-0071-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat